Giorgio Sesti

Pubblicazioni

Titolo Pubblicato in Anno
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9) DIABETES CARE 2020
Serum γ-Glutamyltransferase Concentration Predicts Endothelial Dysfunction in Naïve Hypertensive Patients BIOMEDICINES 2020
Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance CARDIOVASCULAR DIABETOLOGY 2020
Uric acid and vascular damage in essential hypertension. role of insulin resistance NUTRIENTS 2020
The contribution of unrecognized factors to the diabetes epidemic DIABETES/METABOLISM RESEARCH AND REVIEWS 2020
Liraglutide increases serum levels of microRNA-27b, -130a and -210 in patients with type 2 diabetes mellitus. a novel epigenetic effect METABOLITES 2020
Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy DRUGS - REAL WORLD OUTCOMES 2020
Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG). Case Report SN COMPREHENSIVE CLINICAL MEDICINE 2020
Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance DIABETES/METABOLISM RESEARCH AND REVIEWS 2020
Psychological Distress in Patients with Autoimmune Arthritis during the COVID-19 Induced Lockdown in Italy MICROORGANISMS 2020
Relative risk of cardiovascular disease is higher in women with type 2 diabetes, but not in those with prediabetes, as compared with men DIABETES CARE 2020
Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus CIRCULATION 2020
Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes METABOLISM, CLINICAL AND EXPERIMENTAL 2020
HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY 2020
Review of methods for detecting glycemic disorders DIABETES RESEARCH AND CLINICAL PRACTICE 2020
HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: A longitudinal study DIABETES/METABOLISM RESEARCH AND REVIEWS 2020
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials DIABETES RESEARCH AND CLINICAL PRACTICE 2020
Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system? JOURNAL OF MEDICAL VIROLOGY 2020
Impact of mediterranean diet on disease activity and gut microbiota composition of rheumatoid arthritis patients MICROORGANISMS 2020
Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents DIABETES THERAPY 2019

ERC

  • LS4_9
  • LS4_10

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

- Meccanismi molecolari dell’azione insulinica e della funzione pancreatica;

- Fisiopatologia del diabete tipo 2 e dell’obesità;

- Genetica dell’insulino-resistenza, del diabete tipo 2 e dell’obesità;

- Sindrome metabolica e prediabete;

- Obesità metabolicamente sana;

- Trattamento del diabete tipo 2;

- Ruolo dell’IGF-1 nella patologia cardiovascolare e metabolica;

- Infiammazione, disfunzione endoteliale e patologia cardiovascolare;

- Epatopatie croniche e danno cardio-metabolico

Keywords

Diabetes Mellitus
obesity
cardiovascular disease

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma